Laboratory Compound Profile
Ultima-Oxa 50 is a laboratory-grade oxandrolone preparation manufactured by Ultima Pharmaceuticals exclusively for controlled research applications. As a synthetic derivative of dihydrotestosterone, this anabolic-androgenic steroid compound exhibits unique molecular properties that make it valuable for investigating androgenic receptor binding mechanisms, protein synthesis pathways, and metabolic modulation in controlled laboratory environments. Researchers at Stroid UK Shop can examine this compound’s distinctive 5α-reduced structure and its tissue-selective androgenic activity profiles.
Scientific Research Applications
Laboratory studies with oxandrolone have investigated its role in nitrogen retention mechanisms, collagen synthesis pathways, and hepatic metabolism research. The compound’s unique 2-oxa substitution and methylation at the 17α position create distinct pharmacokinetic properties that researchers examine in oral steroid research protocols. Scientific investigations focus on its tissue-selective androgenic activity, particularly its reduced hepatotoxic profile compared to other methylated compounds. Research applications include studying bone metabolism, wound healing processes, and protein turnover mechanisms in controlled laboratory models. Comparative studies with selective androgen receptor modulators examine tissue selectivity differences and receptor binding affinities.
Technical Specifications
| Parameter | Specification |
|---|---|
| Chemical Name | 17β-hydroxy-17α-methyl-2-oxa-5α-androstan-3-one |
| CAS Number | 53-39-4 |
| Molecular Formula | C₁₉H₃₀O₃ |
| Molecular Weight | 306.44 g/mol |
| Concentration | 50mg per unit |
| Storage Requirements | Room temperature, dry environment |
Research protocols examining oxandrolone often investigate its metabolic pathways, including its resistance to aromatisation and reduced 5α-reduction compared to testosterone. Laboratory studies with research peptides frequently examine synergistic mechanisms between anabolic compounds and growth factor signalling pathways.
Research Compliance Statement
Ultima-Oxa 50 is manufactured exclusively for in-vitro laboratory research applications and controlled scientific investigations. This product is not intended for human consumption, therapeutic use, or any application outside of certified laboratory environments. Researchers must ensure compliance with local regulations governing controlled substances and maintain proper laboratory documentation for all research protocols involving this compound.
